Discover 477 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 477
FeaturedActive & Responsive
Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety
for
Depression
Location: 1 recruiting location
Sponsor: Ocean State Research Institute, Inc.
Sex: All
Age: 22 - 70+
Code: NCT05147142
Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: 40 recruiting locations
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
Mobile Peer Support for OUD Recovery
for
Opioid Use Disorder
Location: 2 recruiting locations
Sponsor: Brown University
Sex: All
Age: 18+
Code: NCT05405712
Recruiting
Active & Responsive
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
for
Intracranial Arteriosclerosis, Stroke
Location: 77 recruiting locations
Sponsor: University of Florida
Sex: All
Age: 30+
Code: NCT05047172
Phase3, Recruiting
Active & Responsive
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Get alerts for new trials in your area by subscribing now
New
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: 8 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase2, Recruiting
New
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
for
Alcohol Use Disorder (AUD), PTSD
Location: 1 recruiting location
Sponsor: University of Rhode Island
Sex: All
Age: 18+
Code: NCT07217795
Recruiting
New
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: 37 recruiting locations
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06890338
Phase2, Recruiting
New
Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings
for
Obsessive Compulsive Disorder (OCD),
Location: 1 recruiting location
Sponsor: Bradley Hospital
Sex: All
Age: 5 - 18
Code: NCT06934525
Recruiting
New
A Study of Brenipatide in Participants With Alcohol Use Disorder